Finemedix Co., Ltd. (KOSDAQ:387570)
South Korea · Delayed Price · Currency is KRW 7,540.00
+120.00 (1.62%)
At close: Aug 4, 2025, 3:30 PM KST
Finemedix Revenue
Finemedix had revenue of 1.90B KRW in the quarter ending March 31, 2025, with 7.08% growth. This brings the company's revenue in the last twelve months to 10.09B, up 3.65% year-over-year. In the year 2024, Finemedix had annual revenue of 9.96B, down -1.91%.
Revenue (ttm)
10.09B
Revenue Growth
+3.65%
P/S Ratio
4.06
Revenue / Employee
144.08M
Employees
70
Market Cap
40.95B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 9.96B | -193.73M | -1.91% |
| Dec 31, 2023 | 10.15B | 2.01B | 24.71% |
| Dec 31, 2022 | 8.14B | 888.41M | 12.25% |
| Dec 31, 2021 | 7.25B | -656.61M | -8.30% |
| Dec 31, 2020 | 7.91B | 299.80M | 3.94% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 308.10T |
| SK hynix | 77.21T |
| LG Energy Solution | 25.76T |
| Samsung Biologics | 4,898.69B |
| Hanwha Aerospace | 15.28T |
| Hyundai Motor Company | 178.98T |
| HD Hyundai Heavy Industries | 15.32T |
| Doosan Enerbility | 15.88T |